| Product Code: ETC10738258 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Japan Orphan Drug Market Overview |
3.1 Japan Country Macro Economic Indicators |
3.2 Japan Orphan Drug Market Revenues & Volume, 2021 & 2031F |
3.3 Japan Orphan Drug Market - Industry Life Cycle |
3.4 Japan Orphan Drug Market - Porter's Five Forces |
3.5 Japan Orphan Drug Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Japan Orphan Drug Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.7 Japan Orphan Drug Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Japan Orphan Drug Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Japan Orphan Drug Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of rare diseases in Japan |
4.2.2 Favorable government initiatives and policies to promote orphan drug development |
4.2.3 Growing awareness and demand for orphan drugs among patients and healthcare providers |
4.3 Market Restraints |
4.3.1 High cost of orphan drugs leading to affordability issues |
4.3.2 Limited patient population for orphan drugs compared to traditional pharmaceuticals |
5 Japan Orphan Drug Market Trends |
6 Japan Orphan Drug Market, By Types |
6.1 Japan Orphan Drug Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Japan Orphan Drug Market Revenues & Volume, By Type, 2021 - 2031F |
6.1.3 Japan Orphan Drug Market Revenues & Volume, By Biologics, 2021 - 2031F |
6.1.4 Japan Orphan Drug Market Revenues & Volume, By Small Molecules, 2021 - 2031F |
6.1.5 Japan Orphan Drug Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.6 Japan Orphan Drug Market Revenues & Volume, By Cell Therapy, 2021 - 2031F |
6.1.7 Japan Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.2 Japan Orphan Drug Market, By Therapeutic Area |
6.2.1 Overview and Analysis |
6.2.2 Japan Orphan Drug Market Revenues & Volume, By Oncology, 2021 - 2031F |
6.2.3 Japan Orphan Drug Market Revenues & Volume, By Genetic Disorders, 2021 - 2031F |
6.2.4 Japan Orphan Drug Market Revenues & Volume, By Neurological Disorders, 2021 - 2031F |
6.2.5 Japan Orphan Drug Market Revenues & Volume, By Autoimmune Disorders, 2021 - 2031F |
6.2.6 Japan Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3 Japan Orphan Drug Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Japan Orphan Drug Market Revenues & Volume, By Prescription Drugs, 2021 - 2031F |
6.3.3 Japan Orphan Drug Market Revenues & Volume, By Over-the-Counter, 2021 - 2031F |
6.3.4 Japan Orphan Drug Market Revenues & Volume, By Specialty Drugs, 2021 - 2031F |
6.3.5 Japan Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.3.6 Japan Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
6.4 Japan Orphan Drug Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Japan Orphan Drug Market Revenues & Volume, By Hospital Pharmacies, 2021 - 2031F |
6.4.3 Japan Orphan Drug Market Revenues & Volume, By Retail Pharmacies, 2021 - 2031F |
6.4.4 Japan Orphan Drug Market Revenues & Volume, By Online Pharmacies, 2021 - 2031F |
6.4.5 Japan Orphan Drug Market Revenues & Volume, By Specialty Clinics, 2021 - 2031F |
6.4.6 Japan Orphan Drug Market Revenues & Volume, By Others, 2021 - 2031F |
7 Japan Orphan Drug Market Import-Export Trade Statistics |
7.1 Japan Orphan Drug Market Export to Major Countries |
7.2 Japan Orphan Drug Market Imports from Major Countries |
8 Japan Orphan Drug Market Key Performance Indicators |
8.1 Number of orphan drug designations granted by the Japanese regulatory authorities |
8.2 Research and development investment in orphan drug development in Japan |
8.3 Number of clinical trials for orphan drugs conducted in Japan |
8.4 Patient access and reimbursement rates for orphan drugs in Japan |
8.5 Adoption rate of orphan drugs by healthcare providers in Japan |
9 Japan Orphan Drug Market - Opportunity Assessment |
9.1 Japan Orphan Drug Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Japan Orphan Drug Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.3 Japan Orphan Drug Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Japan Orphan Drug Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Japan Orphan Drug Market - Competitive Landscape |
10.1 Japan Orphan Drug Market Revenue Share, By Companies, 2024 |
10.2 Japan Orphan Drug Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here